Leerink Partners Cuts Price Target on Conmed (CNMD) to $43; Reiterates Market Perform

October 28, 2016 9:04 AM

Leerink Partners maintained a Market Perform rating on CONMED (NASDAQ: CNMD), and cut the price target to $43.00 (from $47.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found